{"transactions":[{"id":705081,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-22T00:39:32.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":10826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 amendment is being filed solely to amend the Form 4 filed on June 16, 2026 to correct the number of options awarded to the Reporting Person on June 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4 amendment is being filed solely to amend the Form 4 filed on June 16, 2026 to correct the number of options awarded to the Reporting Person on June 12, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment is being filed solely to amend the Form 4 filed on June 16, 2026 to correct the number of options awarded to the Reporting Person on June 12, 2026."}],"balance_after":10826,"derivative":{"exercise_price":12.64,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":10826},"source":{"system":"sec-edgar","filing":"0001193125-26-310982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312526310982/ownership.xml","form_type":"4/A","original_submission_date":"2026-06-16"}},{"id":735788,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:30:17.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":9810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":9810,"derivative":{"exercise_price":12.64,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":9810},"source":{"system":"sec-edgar","filing":"0001193125-26-272684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312526272684/ownership.xml","form_type":"4"}},{"id":926750,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-31T00:00:02.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":20363,"price":2.75,"value":55998.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was granted to the Reporting Person, a director of the Issuer pursuant to the 2024 Stock Option and Incentive Plan and pursuant to the Issuer's non-employee director compensation policy. This option shall vest in four equal quarterly installments as of the last date of each calendar quarter subject to the Reporting Person's continued service through such date and represents the Reporting Person's election to receive stock options in lieu of cash retainer fees. Due to administrative oversight this option award initially was not reported."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the Reporting Person, a director of the Issuer pursuant to the 2024 Stock Option and Incentive Plan and pursuant to the Issuer's non-employee director compensation policy. This option shall vest in four equal quarterly installments as of the last date of each calendar quarter subject to the Reporting Person's continued service through such date and represents the Reporting Person's election to receive stock options in lieu of cash retainer fees. Due to administrative oversight this option award initially was not reported."}],"balance_after":20363,"derivative":{"exercise_price":3.6,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":20363},"source":{"system":"sec-edgar","filing":"0001193125-26-032246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312526032246/ownership.xml","form_type":"4"}},{"id":970652,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":24.61,"expiration_date":"2032-01-31","underlying":"Common Shares","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970651,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":16.07,"expiration_date":"2033-02-02","underlying":"Common Shares","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970650,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":36.09,"expiration_date":"2034-01-31","underlying":"Common Shares","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970649,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":41.65,"expiration_date":"2035-01-29","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970648,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":351628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":24.43,"expiration_date":"2031-02-16","underlying":"Common Shares","underlying_shares":351628},"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970647,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":312620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":13.52,"expiration_date":"2030-01-03","underlying":"Common Shares","underlying_shares":312620},"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970646,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":9192,"price":97,"value":891624.0,"ownership":{"direct":false,"nature":"Emily Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970645,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":9192,"price":97,"value":891624.0,"ownership":{"direct":false,"nature":"Kristian Ante Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970644,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":9191,"price":97,"value":891527.0,"ownership":{"direct":false,"nature":"Madeleine Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970643,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":9191,"price":97,"value":891527.0,"ownership":{"direct":false,"nature":"Katrina Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970642,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":16372,"price":97,"value":1588084.0,"ownership":{"direct":false,"nature":"Ante S Lundberg Qualified Annuity Int Trust X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":970641,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-12-12T18:59:05.000Z","date":"2025-12-12","kind":"other","planned":false,"acquired":false,"shares":30297,"price":97,"value":2938809.0,"ownership":{"direct":false,"nature":"Ante S Lundberg Qualified Annuity Interest Trust XI"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-317947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525317947/ownership.xml","form_type":"4"}},{"id":986082,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":true,"shares":2539,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Emily Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":9192,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986081,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":true,"shares":2539,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Kristian Ante Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":9192,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986080,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":true,"shares":2539,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Madeleine Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":9191,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986079,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":true,"shares":2538,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Katrina Lundberg 2018 Irrevocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":9191,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986078,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":24229,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante S Lundberg Qualified Annuity Int Trust X"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":16372,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986077,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":22449,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante Sven Lundberg Qualified Annuity Interest Trust IX"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986076,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":52369,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante Sven Lundberg Qualified Annuity Interest Trust VIII"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986075,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":12215,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante S Lundberg Qualified Annuity Int Trust VII"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986074,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":14198,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante Sven Lundberg Qualified Annuity Interest Trust VI"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986073,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":true,"shares":30297,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante  S Lundberg Qualified Annuity Interest Trust XI"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries."}],"balance_after":30297,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":986072,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-11-28T16:30:08.000Z","date":"2025-11-25","kind":"gift","planned":false,"acquired":false,"shares":30297,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-302579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000119312525302579/ownership.xml","form_type":"4"}},{"id":1013077,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-28T01:34:35.000Z","date":"2025-10-23","kind":"grant","planned":false,"acquired":true,"shares":53521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) October 23, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":53521,"derivative":{"exercise_price":2.8,"expiration_date":"2035-10-22","underlying":"Common Stock","underlying_shares":53521},"source":{"system":"sec-edgar","filing":"0001193125-25-252000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312525252000/ownership.xml","form_type":"4"}},{"id":1135497,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T21:45:14.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 22, 2026 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":30000,"derivative":{"exercise_price":0.1868,"expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-014530","document":"form4-05232025_050511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000141588925014530/form4-05232025_050511.xml","form_type":"4"}},{"id":1168191,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-04-21T16:05:04.000Z","date":"2025-04-17","kind":"exercise","planned":false,"acquired":false,"shares":26500,"price":13.52,"value":358280.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter."}],"balance_after":312620,"derivative":{"exercise_price":13.52,"expiration_date":"2030-01-03","underlying":"Common Shares","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0000950170-25-056278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025056278/ownership.xml","form_type":"4"}},{"id":1168190,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-04-21T16:05:04.000Z","date":"2025-04-17","kind":"exercise","planned":false,"acquired":false,"shares":3797,"price":12.54,"value":47614.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a three-year period commencing March 19, 2019. One-third vest after one year and in 24 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":12.54,"expiration_date":"2029-03-19","underlying":"Common Shares","underlying_shares":3797},"source":{"system":"sec-edgar","filing":"0000950170-25-056278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025056278/ownership.xml","form_type":"4"}},{"id":1168189,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-04-21T16:05:04.000Z","date":"2025-04-17","kind":"exercise","planned":false,"acquired":true,"shares":26500,"price":13.52,"value":358280.0,"ownership":{"direct":true},"balance_after":30297,"source":{"system":"sec-edgar","filing":"0000950170-25-056278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025056278/ownership.xml","form_type":"4"}},{"id":1168188,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-04-21T16:05:04.000Z","date":"2025-04-17","kind":"exercise","planned":false,"acquired":true,"shares":3797,"price":12.54,"value":47614.38,"ownership":{"direct":true},"balance_after":3797,"source":{"system":"sec-edgar","filing":"0000950170-25-056278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025056278/ownership.xml","form_type":"4"}},{"id":1242411,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":23140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.54 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date; provided that in the event (i) the option is exercised prior to the one-year anniversary of the Repricing Date, (ii) the Reporting Person's employment is terminated by the Company prior to the one-year anniversary of the Repricing Date due to Cause (as defined in the 2024 Plan) or (iii) the Reporting Person resigns for any reason prior to the one-year anniversary of the Repricing Date, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":23140,"derivative":{"exercise_price":2.54,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":23140},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242410,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":23140},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242409,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":23140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This option was granted to the Reporting Person, a director of the Issuer pursuant to the 2024 Plan and pursuant to the Issuer's non-employee director compensation policy. This option represents the Reporting Person's election to receive stock options in lieu of cash retainer fees Due to administrative oversight this option award initially was not reported."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted to the Reporting Person, a director of the Issuer pursuant to the 2024 Plan and pursuant to the Issuer's non-employee director compensation policy. This option represents the Reporting Person's election to receive stock options in lieu of cash retainer fees Due to administrative oversight this option award initially was not reported."}],"balance_after":23140,"derivative":{"exercise_price":3.2,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":23140},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242408,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":44.4,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":1316},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242407,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":12767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.54 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date; provided that in the event (i) the option is exercised prior to the one-year anniversary of the Repricing Date, (ii) the Reporting Person's employment is terminated by the Company prior to the one-year anniversary of the Repricing Date due to Cause (as defined in the 2024 Plan) or (iii) the Reporting Person resigns for any reason prior to the one-year anniversary of the Repricing Date, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":12767,"derivative":{"exercise_price":2.54,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":12767},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242406,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.82,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":12767},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242405,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":2880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.54 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date; provided that in the event (i) the option is exercised prior to the one-year anniversary of the Repricing Date, (ii) the Reporting Person's employment is terminated by the Company prior to the one-year anniversary of the Repricing Date due to Cause (as defined in the 2024 Plan) or (iii) the Reporting Person resigns for any reason prior to the one-year anniversary of the Repricing Date, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2880,"derivative":{"exercise_price":2.54,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":2880},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242404,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":7.29,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":2880},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242403,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":6238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.54 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date; provided that in the event (i) the option is exercised prior to the one-year anniversary of the Repricing Date, (ii) the Reporting Person's employment is terminated by the Company prior to the one-year anniversary of the Repricing Date due to Cause (as defined in the 2024 Plan) or (iii) the Reporting Person resigns for any reason prior to the one-year anniversary of the Repricing Date, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":6238,"derivative":{"exercise_price":2.54,"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":6238},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242402,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.13,"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":6238},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242401,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":2013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $2.54 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Date; provided that in the event (i) the option is exercised prior to the one-year anniversary of the Repricing Date, (ii) the Reporting Person's employment is terminated by the Company prior to the one-year anniversary of the Repricing Date due to Cause (as defined in the 2024 Plan) or (iii) the Reporting Person resigns for any reason prior to the one-year anniversary of the Repricing Date, the exercise price will be increased to the exercise price of the cancelled option in exchange for which this option was granted."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2013,"derivative":{"exercise_price":2.54,"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":2013},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1242400,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T02:52:54.000Z","date":"2025-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2025, the Issuer's board of directors approved an option repricing (\"Repricing Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Q32 Bio Inc. 2017 Stock Option and Grant Plan (the \"2017 Plan\") or the Q32 Bio Inc. 2024 Stock Option and Incentive Plan (the \"2024 Plan\"), as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":3.13,"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":2013},"source":{"system":"sec-edgar","filing":"0000950170-25-028243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017025028243/ownership.xml","form_type":"4"}},{"id":1252231,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-02-21T16:05:20.000Z","date":"2025-02-19","kind":"gift","planned":false,"acquired":true,"shares":40601,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Ante S Lundberg Qualified Annuity Int Trust X"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On February 19, 2025, the reporting person transferred 40,601 shares of Issuer common shares to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust"}],"balance_after":40601,"source":{"system":"sec-edgar","filing":"0000950170-25-024836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025024836/ownership.xml","form_type":"4"}},{"id":1252230,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-02-21T16:05:20.000Z","date":"2025-02-19","kind":"gift","planned":false,"acquired":false,"shares":40601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On February 19, 2025, the reporting person transferred 40,601 shares of Issuer common shares to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-024836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025024836/ownership.xml","form_type":"4"}},{"id":1263250,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-02-18T17:43:48.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":16372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a four-year period from January 1, 2021. 25% vest on January 1, 2022 and in 36 equal monthly installments thereafter."}],"balance_after":351628,"derivative":{"exercise_price":24.43,"expiration_date":"2031-02-16","underlying":"Common Shares","underlying_shares":16372},"source":{"system":"sec-edgar","filing":"0000950170-25-022520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025022520/ownership.xml","form_type":"4"}},{"id":1263249,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Common Shares","published_at":"2025-02-18T17:43:48.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":16372,"price":24.43,"value":399967.96,"ownership":{"direct":true},"balance_after":40601,"source":{"system":"sec-edgar","filing":"0000950170-25-022520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025022520/ownership.xml","form_type":"4"}},{"id":1289131,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2025-01-31T16:31:23.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a four-year period from January 1, 2025. 25% vest on January 1, 2026 and in 36 equal monthly installments thereafter."}],"balance_after":300000,"derivative":{"exercise_price":41.65,"expiration_date":"2035-01-29","underlying":"Common Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-25-011796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017025011796/ownership.xml","form_type":"4"}},{"id":1398341,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-28T01:57:24.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":1316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":1316,"derivative":{"exercise_price":44.4,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":1316},"source":{"system":"sec-edgar","filing":"0000950170-24-110150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017024110150/ownership.xml","form_type":"4"}},{"id":1500562,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T20:10:22.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 23, 2025 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject\nto the Reporting Person's continued service as a director through such date."}],"balance_after":30000,"derivative":{"exercise_price":1.61,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-24-014649","document":"form4-05282024_040517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000141588924014649/form4-05282024_040517.xml","form_type":"4"}},{"id":1521806,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PEO"}}],"security":"Share Option (right to buy)","published_at":"2024-05-09T16:30:42.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On February 1, 2024, the Board of Directors approved the grant of options to purchase the common shares, at an exercise price of $36.09 per share, subject to the Company's general meeting resolving upon, and the Board having implemented through an amendment to the Company's articles of association, an increase in the authorized share capital sufficient to satisfy the award set forth (the \"Shareholder Approval Condition\"). On May 7, 2024, the shareholders approved the amendment to the Company's articles of association, including the increase in the authorized share capital satisfying the Shareholder Approval Condition."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest over a four-year period from January 1, 2024. 25% vest on January 1, 2025 and in 36 equal monthly installments thereafter."}],"balance_after":360000,"derivative":{"exercise_price":36.09,"expiration_date":"2034-01-31","underlying":"Common Shares","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0000950170-24-057086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000095017024057086/ownership.xml","form_type":"4"}},{"id":1559200,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T21:25:24.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":12767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":12767,"derivative":{"exercise_price":16.82,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":12767},"source":{"system":"sec-edgar","filing":"0000950170-24-037368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017024037368/ownership.xml","form_type":"4"}},{"id":1870200,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:34:32.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) May 26, 2024 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":30000,"derivative":{"exercise_price":4.79,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-033803","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000120919123033803/doc4.xml","form_type":"4"}},{"id":2032014,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2023-02-03T16:23:59.000Z","date":"2023-02-02","kind":"grant","acquired":true,"shares":380000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a four-year period from January 1, 2023. 25% vest on January 1, 2024 and in 36 equal monthly installments thereafter."}],"balance_after":380000,"derivative":{"exercise_price":16.07,"expiration_date":"2033-02-02","underlying":"Common Shares","underlying_shares":380000},"source":{"system":"sec-edgar","filing":"0001209191-23-006850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919123006850/doc4.xml","form_type":"4"}},{"id":2125115,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2022-11-03T14:07:58.000Z","date":"2022-11-03","kind":"purchase","acquired":true,"shares":14706,"price":14.3772,"value":211431.1032,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to 10B5-1 plan dated 6/10/2022"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.36 to $16.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":40576,"source":{"system":"sec-edgar","filing":"0001209191-22-055466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919122055466/doc4.xml","form_type":"4"}},{"id":2175741,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Stock","published_at":"2022-08-23T16:09:27.000Z","date":"2022-08-22","kind":"purchase","acquired":true,"shares":5826,"price":22.9245,"value":133558.137,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased in pursuant to 10B5-1 plan dated 6/10/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.73 to $23.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":25870,"source":{"system":"sec-edgar","filing":"0001209191-22-047168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919122047168/doc4.xml","form_type":"4"}},{"id":2176691,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Stock","published_at":"2022-08-22T15:02:24.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":704,"price":22.9928,"value":16186.9312,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased in pursuant to 10B5-1 plan dated 6/10/2022"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.99 to $23.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above"}],"balance_after":20044,"source":{"system":"sec-edgar","filing":"0001209191-22-046994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919122046994/doc4.xml","form_type":"4"}},{"id":2207908,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2022-07-13T10:13:23.000Z","date":"2022-07-12","kind":"purchase","acquired":true,"shares":4340,"price":22.9688,"value":99684.592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sold in pursuant to 10B5-1 plan dated 6/10/22"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.75 to $23.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":19340,"source":{"system":"sec-edgar","filing":"0001209191-22-042002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919122042002/doc4.xml","form_type":"4"}},{"id":2230133,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T21:07:57.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":16911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 14, 2023 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date."}],"balance_after":16911,"derivative":{"exercise_price":4.26,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":16911},"source":{"system":"sec-edgar","filing":"0001209191-22-037512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000120919122037512/doc4.xml","form_type":"4"}},{"id":2415783,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2022-02-02T14:02:38.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a four-year period from January 1, 2022. 25% vest on January 1, 2023 and in 36 equal monthly installments thereafter."}],"balance_after":295000,"derivative":{"exercise_price":24.61,"expiration_date":"2032-01-31","underlying":"Common Shares","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001209191-22-006290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919122006290/doc4.xml","form_type":"4"}},{"id":2614173,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2021-08-04T15:56:14.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":12627,"price":13.52,"value":170717.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter."}],"balance_after":339120,"derivative":{"exercise_price":13.52,"expiration_date":"2030-01-03","underlying":"Common Shares","underlying_shares":12627},"source":{"system":"sec-edgar","filing":"0001209191-21-049593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121049593/doc4.xml","form_type":"4"}},{"id":2614172,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2021-08-04T15:56:14.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":2373,"price":12.54,"value":29757.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a three-year period commencing March 19, 2019. One-third vest after one year and in 24 equal monthly installments thereafter."}],"balance_after":3797,"derivative":{"exercise_price":12.54,"expiration_date":"2029-03-19","underlying":"Common Shares","underlying_shares":2373},"source":{"system":"sec-edgar","filing":"0001209191-21-049593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121049593/doc4.xml","form_type":"4"}},{"id":2614171,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2021-08-04T15:56:14.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":2373,"price":12.54,"value":29757.42,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-21-049593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121049593/doc4.xml","form_type":"4"}},{"id":2614170,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2021-08-04T15:56:14.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":12627,"price":13.52,"value":170717.04,"ownership":{"direct":true},"balance_after":12627,"source":{"system":"sec-edgar","filing":"0001209191-21-049593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121049593/doc4.xml","form_type":"4"}},{"id":2769050,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2021-03-29T19:18:26.000Z","date":"2021-03-25","kind":"gift","acquired":false,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 25, 2021, the reporting person transferred 74,000 shares of Issuer common shares to a family trust of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-023481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121023481/doc4.xml","form_type":"4"}},{"id":2811117,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2021-03-03T16:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":63170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter."}],"balance_after":351747,"derivative":{"exercise_price":13.52,"expiration_date":"2030-01-03","underlying":"Common Shares","underlying_shares":63170},"source":{"system":"sec-edgar","filing":"0001209191-21-016770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121016770/doc4.xml","form_type":"4"}},{"id":2811116,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2021-03-03T16:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":10830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a three-year period commencing March 19, 2019. One-third vest after one year and in 24 equal monthly installments thereafter."}],"balance_after":6170,"derivative":{"exercise_price":12.54,"expiration_date":"2029-03-19","underlying":"Common Shares","underlying_shares":10830},"source":{"system":"sec-edgar","filing":"0001209191-21-016770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121016770/doc4.xml","form_type":"4"}},{"id":2811115,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2021-03-03T16:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":63170,"price":13.52,"value":854058.4,"ownership":{"direct":true},"balance_after":74000,"source":{"system":"sec-edgar","filing":"0001209191-21-016770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121016770/doc4.xml","form_type":"4"}},{"id":2811114,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Common Shares","published_at":"2021-03-03T16:00:13.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":10830,"price":12.54,"value":135808.2,"ownership":{"direct":true},"balance_after":10830,"source":{"system":"sec-edgar","filing":"0001209191-21-016770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121016770/doc4.xml","form_type":"4"}},{"id":2848778,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2021-02-18T16:00:18.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":368000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a four-year period from January 1, 2021. 25% vest on January 1, 2022 and in 36 equal monthly installments thereafter."}],"balance_after":368000,"derivative":{"exercise_price":24.43,"expiration_date":"2031-02-16","underlying":"Common Shares","underlying_shares":368000},"source":{"system":"sec-edgar","filing":"0001209191-21-011775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919121011775/doc4.xml","form_type":"4"}},{"id":2872346,"issuer":{"id":4763,"kind":"organization","name":"Vor Biopharma Inc.","symbol":"VOR"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-09T22:14:03.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":16900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares underlying the option vest in equal monthly installments commencing on March 5, 2021, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date."}],"balance_after":16900,"derivative":{"exercise_price":18,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":16900},"source":{"system":"sec-edgar","filing":"0001209191-21-008886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817229/000120919121008886/doc4.xml","form_type":"4"}},{"id":3317388,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO & PFO"}}],"security":"Share Option (right to buy)","published_at":"2020-01-06T17:00:19.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":414917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter."}],"balance_after":414917,"derivative":{"exercise_price":13.52,"expiration_date":"2030-01-03","underlying":"Common Shares","underlying_shares":414917},"source":{"system":"sec-edgar","filing":"0001209191-20-001952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651311/000120919120001952/doc4.xml","form_type":"4"}},{"id":4457268,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series B Preferred Shares","published_at":"2017-02-10T19:16:28.000Z","date":"2016-10-24","kind":"exercise","acquired":false,"shares":55217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These securities were convertible at any time on a one-for-one basis into shares of the Issuer's Common Stock at the holder's election and automatically upon the closing of the Issuer's initial public offering. These securities do not have an expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were convertible at any time on a one-for-one basis into shares of the Issuer's Common Stock at the holder's election and automatically upon the closing of the Issuer's initial public offering. These securities do not have an expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities were convertible at any time on a one-for-one basis into shares of the Issuer's Common Stock at the holder's election and automatically upon the closing of the Issuer's initial public offering. These securities do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These securities were convertible at any time on a one-for-one basis into shares of the Issuer's Common Stock at the holder's election and automatically upon the closing of the Issuer's initial public offering. These securities do not have an expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":55217},"source":{"system":"sec-edgar","filing":"0000899243-17-003419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317003419/doc4.xml","form_type":"4"}},{"id":4457267,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2017-02-10T19:16:28.000Z","date":"2016-10-24","kind":"purchase","acquired":true,"shares":400,"price":14,"value":5600.0,"ownership":{"direct":false,"nature":"By wife"},"balance_after":505617,"source":{"system":"sec-edgar","filing":"0000899243-17-003419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317003419/doc4.xml","form_type":"4"}},{"id":4457266,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":27986,"kind":"person","name":"Lundberg Sven Ante","position":1,"cik":"0001682126","reported_name":"Lundberg Sven Ante","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2017-02-10T19:16:28.000Z","date":"2016-10-24","kind":"exercise","acquired":true,"shares":55217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were convertible at any time on a one-for-one basis into shares of the Issuer's Common Stock at the holder's election and automatically upon the closing of the Issuer's initial public offering. These securities do not have an expiration date."}],"balance_after":505217,"source":{"system":"sec-edgar","filing":"0000899243-17-003419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924317003419/doc4.xml","form_type":"4"}}]}